Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Pleiotropic effects of ezetimibe/simvastatin vs. high dose simvastatin.

Pesaro AE, Serrano CV Jr, Fernandes JL, Cavalcanti AB, Campos AH, Martins HS, Maranhão RC, de Lemos JA, Souza HP, Nicolau JC.

Int J Cardiol. 2012 Jul 26;158(3):400-4. doi: 10.1016/j.ijcard.2011.01.062. Epub 2011 Feb 21.

2.

No effect of lipid lowering on platelet activity in patients with coronary artery disease and type 2 diabetes or impaired glucose tolerance.

Malmström RE, Settergren M, Böhm F, Pernow J, Hjemdahl P.

Thromb Haemost. 2009 Jan;101(1):157-64.

PMID:
19132203
3.

Increasing doses of simvastatin versus combined ezetimibe/simvastatin: effect on circulating endothelial progenitor cells.

Pesaro AE, Serrano CV Jr, Katz M, Marti L, Fernandes JL, Parra PR, Campos AH.

J Cardiovasc Pharmacol Ther. 2013 Sep;18(5):447-52. doi: 10.1177/1074248413489771. Epub 2013 Jun 5.

PMID:
23739650
4.
5.

Comparison of effects of morning versus evening administration of ezetimibe/simvastatin on serum cholesterol in patients with primary hypercholesterolemia.

Yoon HS, Kim SH, Kim JK, Ko SH, Ko JE, Park SJ, Park MG, Lee JH, Hyon MS.

Ann Pharmacother. 2011 Jul;45(7-8):841-9. doi: 10.1345/aph.1P511. Epub 2011 Jun 21. Erratum in: Ann Pharmacother. 2011 Sep;45(9):1172.

PMID:
21693699
6.

Ezetimibe's effect on platelet aggregation and LDL tendency to peroxidation in hypercholesterolaemia as monotherapy or in addition to simvastatin.

Hussein O, Minasian L, Itzkovich Y, Shestatski K, Solomon L, Zidan J.

Br J Clin Pharmacol. 2008 May;65(5):637-45. doi: 10.1111/j.1365-2125.2007.03080.x. Epub 2008 Jan 30.

7.
8.

Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.

Alvarez-Sala LA, Cachofeiro V, Masana L, Suarez C, Pinilla B, Plana N, Trias F, Moreno MA, Gambus G, Lahera V, Pintó X.

Clin Ther. 2008 Jan;30(1):84-97. doi: 10.1016/j.linthera.2008.01.013.

PMID:
18343245
10.

Atheroprotective lipoprotein effects of a niacin-simvastatin combination compared to low- and high-dose simvastatin monotherapy.

Airan-Javia SL, Wolf RL, Wolfe ML, Tadesse M, Mohler E, Reilly MP.

Am Heart J. 2009 Apr;157(4):687.e1-8. doi: 10.1016/j.ahj.2009.01.001. Epub 2009 Feb 23.

11.

Treatment of high-risk patients with ezetimibe plus simvastatin co-administration versus simvastatin alone to attain National Cholesterol Education Program Adult Treatment Panel III low-density lipoprotein cholesterol goals.

Feldman T, Koren M, Insull W Jr, McKenney J, Schrott H, Lewin A, Shah S, Sidisin M, Cho M, Kush D, Mitchel Y.

Am J Cardiol. 2004 Jun 15;93(12):1481-6.

PMID:
15194017
12.

Safety and efficacy of ezetimibe/simvastatin combination versus atorvastatin alone in adults ≥65 years of age with hypercholesterolemia and with or at moderately high/high risk for coronary heart disease (the VYTELD study).

Foody JM, Brown WV, Zieve F, Adewale AJ, Flaim D, Lowe RS, Jones-Burton C, Tershakovec AM.

Am J Cardiol. 2010 Nov 1;106(9):1255-63. doi: 10.1016/j.amjcard.2010.06.051.

PMID:
21029821
13.
16.

The effect of simvastatin, ezetimibe and their combination on the lipid profile, arterial stiffness and inflammatory markers.

Efrati S, Averbukh M, Dishy V, Faygenzo M, Friedensohn L, Golik A.

Eur J Clin Pharmacol. 2007 Feb;63(2):113-21. Epub 2007 Jan 3.

PMID:
17200833
17.

Simvastatin and ezetimibe in addition to nonpharmacological risk factor modification for achieving new low-density lipoprotein cholesterol targets.

Liska B, Khattab AA, Herrmann L, Abdel-Wahab M, Westphal R, Tölg R, Geist V, Richardt G.

Herz. 2008 Jul;33(5):362-7. doi: 10.1007/s00059-008-3084-6. Epub 2008 Sep 5.

PMID:
18773156
18.

Treatment with ezetimibe plus low-dose atorvastatin compared with higher-dose atorvastatin alone: is sufficient cholesterol-lowering enough to inhibit platelets?

Piorkowski M, Fischer S, Stellbaum C, Jaster M, Martus P, Morguet AJ, Schultheiss HP, Rauch U.

J Am Coll Cardiol. 2007 Mar 13;49(10):1035-42. Epub 2007 Feb 23.

19.

Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: the Vytorin Versus Atorvastatin (VYVA) study.

Ballantyne CM, Abate N, Yuan Z, King TR, Palmisano J.

Am Heart J. 2005 Mar;149(3):464-73. Erratum in: Am Heart J. 2005 May;149(5):882.

PMID:
15864235
20.

Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients.

Catapano AL, Davidson MH, Ballantyne CM, Brady WE, Gazzara RA, Tomassini JE, Tershakovec AM.

Curr Med Res Opin. 2006 Oct;22(10):2041-53.

PMID:
17022864
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk